一分钟看懂
这是一项关于非小细胞肺癌的III 期研究，登记的药物或干预包括Calderasib；Pembrolizumab (+) Berahyaluronidase alfa；Pemetrexed；Cisplatin；Carboplatin，当前状态为招募中。登记地点显示中国合肥、北京、福建省、福州等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Calderasib；Pembrolizumab (+) Berahyaluronidase alfa；Pemetrexed；Cisplatin；Carboplatin · III 期
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Anhui Provincial Cancer Hospital ( Site 2708) · 合肥
- Beijing Cancer hospital-Thoracic Cancer Department A ( Site 2700) · 北京
- Beijing Peking Union Medical College Hospital ( Site 2702) · 北京
- The First Affiliated Hospital of Fujian Medical University ( Site 2701) · 福建省
- Fujian Provincial Cancer Hospital ( Site 2706) · 福州
- The First Affiliated Hospital of Xiamen University ( Site 2717) · 福州
- The First Affiliated Hospital.Sun Yat-sen University ( Site 2714) · 广州
- AFFILIATED CANCER HOSPITAL AND INSTITUTE OF GUANGZHOU MEDICAL UNIVERSITY ( Site 2743) · 广州
- Zhujiang Hospital of Southern Medical University ( Site 2744) · 广州
- Affiliated Cancer Hospital of Guangxi Medical University ( Site 2704) · 南宁
- JIAMUSI TUBERCULOSIS HOSPITAL(CANCER HOSPITAL) ( Site 2745) · 佳木斯
- Henan Cancer Hospital ( Site 2746) · 郑州
- Tongji Hospital Tongji Medical,Science & Technology ( Site 2722) · 武汉
- Hubei Cancer Hospital ( Site 2721) · 武汉
- Xiangya Hospital Central South University ( Site 2741) · 长沙
- Hunan Cancer Hospital ( Site 2710) · 长沙
- Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School ( Site 2715) · 南京
- Jiangxi Cancer Hospital ( Site 2725) · 南昌
- The First Affiliated Hospital of Xi'an Jiaotong University ( Site 2729) · 西安
- LinYi Cancer Hospital ( Site 2737) · 临沂
- Shanghai Pulmonary Hospital-Oncology Department ( Site 2723) · 上海
- Shanxi Cancer Hospital ( Site 2728) · 太原
- Sichuan Cancer Hospital. ( Site 2739) · 成都
- West China Hospital Sichuan University ( Site 2735) · 成都
- Chongqing University Cancer Hospital ( Site 2736) · 重庆
- Yunnan Province Cancer Hospital ( Site 2734) · 昆明
- The First Affiliated Hospital, Zhejiang University ( Site 2716) · 杭州
- Sir Run Run Shaw Hospital ( Site 2731) · 杭州
- Zhejiang Cancer Hospital ( Site 2727) · 杭州
- Taizhou Hospital of Zhejiang Province-Respiratory ( Site 2724) · 台州
公开的入选条件
- The main inclusion criteria include but are not limited to the following:
- * Has nonsquamous NSCLC (Stage IIIB, Stage IIIC) not eligible for curative resection or chemoradiation or Stage IV: M1a, M1b, or M1c
- * If human immunodeficiency virus (HIV) positive, must have well controlled HIV on antiretroviral therapy (ART)
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT07190248；登记信息更新于 2026-09-14。